Disease oriented treatment of metastatic colorectal cancer (CRC) with dose-dense 5-FU/Folinic acid (FU/FA) combination chemotherapy

被引：0
|
作者：
Loeffler, TM [1 ]
Droege, C [1 ]
Lenfers, BHM [1 ]
Hausamen, TU [1 ]
机构：
[1] Stadt Kliniken Dortmund, Dept Med, Dortmund, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80661-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
228
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF ADVANCED COLORECTAL (CRC) AND GASTRIC ADENOCARCINOMAS (GC) WITH 5-FU AND HIGH-DOSE FOLINIC ACID (FA)
    MACHOVER, D
    GOLDSCHMIDT, E
    CHOLLET, P
    METZGER, G
    SCHWARZENBERG, L
    MISSET, JL
    TIMUS, M
    VANDENBULCKE, JM
    ZITTOUN, J
    MATHE, G
    ANTICANCER RESEARCH, 1985, 5 (06) : 576 - 576
  • [2] TREATMENT OF ADVANCED COLORECTAL (CRC) AND GASTRIC ADENOCARCINOMAS (GC) WITH 5-FU AND HIGH-DOSE FOLINIC ACID (FA)
    MACHOVER, D
    GOLDSCHMIDT, E
    CHOLLET, P
    METZGER, G
    SCHWARZENBERG, L
    MISSET, JL
    TIMUS, M
    VANDENBULCKE, J
    ZITTOUN, J
    SCHNEIDER, M
    MATHE, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 175 - 175
  • [3] 5-fluorouracil (5-FU),folinic acid (FA) and oxaliplatin (FUFOX) as second chemotherapy in patients with metastatic colorectal cancer (MCRC)
    Andric, Z.
    Murtezani, Z.
    Kovcin, V
    Gutovic, J.
    Kostic, S.
    ANNALS OF ONCOLOGY, 2006, 17 : 66 - 67
  • [4] WEEKLY REGIMEN OF 5-FU VS 5-FU PLUS INTERMEDIATE DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    MARTONI, A
    CRICCA, A
    GUARALDI, M
    COVIZZI, M
    FARRIS, A
    PANNUTI, F
    ANTICANCER RESEARCH, 1992, 12 (03) : 607 - 612
  • [5] Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
    Peeters, M.
    Raoul, J.-L.
    Van Laethem, J.-L.
    Rougier, P.
    Brezault, C.
    Husseini, F.
    Cals, L.
    Zubel, A.
    Vedovato, J.-C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 188 - 188
  • [6] Phase III study of bolus 5-fluorouracil (5-FU)/folinic acid vs high dose 24h 5-FU infusion/folinic acid (FA) plus oxaliplatin(OXA) in metastatic colorectal cancer (MCRC).
    Hospers, G
    Schaapveld, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 254S - 254S
  • [7] Phase I of CPT-11 (CAMPTO®) combined with 5-FU/folinic acid (FA) nordic schedule in first line metastatic colorectal cancer (CRC)
    Ristamäki, R
    Glimelius, B
    Linné, T
    Boussard, B
    Oulid-Aïssa, D
    Pyrhonen, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S79 - S79
  • [8] CHEMOTHERAPY FOR COLORECTAL-CANCER WITH A COMBINATION OF PALA AND 5-FU
    BEDIKIAN, AY
    STROEHLEIN, JR
    KARLIN, DA
    BENNETTS, RW
    BODEY, GP
    VALDIVIESO, M
    CANCER TREATMENT REPORTS, 1981, 65 (9-10): : 747 - 753
  • [9] Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
    Gunnar Folprecht
    Susanne Hamann
    Katharina Schütte
    Tanja Trarbach
    Jan Stoehlmacher-Williams
    Gerhard Ehninger
    BMC Cancer, 14
  • [10] Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
    Folprecht, Gunnar
    Hamann, Susanne
    Schuete, Katharina
    Trarbach, Tanja
    Stoehlmacher-Williams, Jan
    Ehninger, Gerhard
    BMC CANCER, 2014, 14
12345